Table 2. Patient characteristics.
| Patient characteristics | Study cohort (n=142) |
|---|---|
| Age (years) | 68 [66.5–69.5] |
| PCa-negative | 18 (13%) |
| PCa-positive | 124 (87%) |
| Biopsy | 56 (39%) |
| MRI/TRUS fusion targeted biopsy | 29 (52%) |
| Ultrasound-guided punch biopsy | 27 (48%) |
| Prostatectomy | 86 (61%) |
| Median prostate volume (mL) | 41.5 [29.3–60.0] |
| Median lesion volume (mL) | 1.1 [0.44–2.8] |
| Median PSA value (ng/mL) | 7.6 [2.4–12.7] |
| Median PSA density (ng/mL2) | 8.0 [3.7–17.3] |
| Median mADC prostate (mm2/s) | 1,197 [1,129–1,76] |
| Median mADC lesion (mm2/s) | 839 [769–979] |
Variables are shown in median [interquartile ranges] or in count (percentage); PCa, prostate cancer; TRUS, transrectal ultrasonography; PSA, prostate specific antigen; mADC, mean apparent diffusion coefficient.